Barclays raised the firm’s price target on Thermo Fisher to $590 from $555 and keeps an Equal Weight rating on the shares post the Q4 report. The company’s core growth and earnings guidance was reset on GLP-1 payment push-out to 2025, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on TMO:
- Thermo Fisher Scientific Reports Earnings: Did it Beat Estimate Forecasts?
- Thermo Fisher (NYSE:TMO) Drops despite Exceeding Q4 Estimates
- Options Volatility and Implied Earnings Moves Today, January 31, 2024
- Thermo Fisher sees FY24 adjusted EPS $20.95-$22.00, consensus $22.04
- Thermo Fisher reports Q4 adjusted EPS $5.67, consensus $5.64
